Search Results - "Anand, Lovkesh"

Refine Results
  1. 1
  2. 2
  3. 3

    Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis by Anand, Lovkesh, Bihari, Chhagan, Kedarisetty, Chandan K., Rooge, Sheetalnath B., Kumar, Dhananjay, Shubham, Smriti, Kumar, Guresh, Sahney, Amrish, Sharma, Manoj K., Maiwall, Rakhi, Kumar, Anupam, Sarin, Shiv K.

    Published in Liver international (01-01-2019)
    “…Background Exogenous growth factor‐mobilized bone marrow (BM) stem cells have shown a differential response in the management of decompensated cirrhosis (DC)…”
    Get full text
    Journal Article
  4. 4

    A double‐blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism by Sahney, Amrish, Sharma, Barjesh Chander, Jindal, Ankur, Anand, Lovkesh, Arora, Vinod, Vijayaraghavan, Rajan, Dhamija, Ravinder Mohan, Kumar, Guresh, Bhardwaj, Ankit, Sarin, Shiv Kumar

    Published in Liver international (01-04-2019)
    “…Background Parkinsonism like features can be seen in cirrhotics, possibly related to alterations in brain dopamine metabolism, transport and receptor integrity…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Guillain-Barré syndrome in a patient of acute Hepatitis E virus infection associated with genotype 1: Case report and literature review by Choudhary, Manish Chandra, Bajpai, Vijeta, Anand, Lovkesh, Gupta, Ekta

    Published in Intractable & Rare Diseases Research (01-02-2019)
    “…Hepatitis E is a serious public health problem in developing countries. Most of the patients with Hepatitis E virus (HEV) infection present with typical acute…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Sonoclot Signature Analysis in Patients with Liver Disease and Its Correlation with Conventional Coagulation Studies by Rastogi, Archana, Saxena, Priyanka, Sarin, Shiv Kumar, Anand, Lovkesh, Agarwal, Savita, Bihari, Chhagan

    Published in Advances in hematology (2013)
    “…Introduction. Liver disease patients have complex hemostatic defects leading to a delicate, unstable balance between bleeding and thrombosis. Conventional…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months by Vijayaraghavan, Rajan, Sarin, Shiv K., Bharadwaj, Ankit, Anand, Lovkesh, Maiwall, Rakhi, Choudhury, Ashok, Benjamin, Jaya, Kanal, Uma, Jamwal, Kapil Dev

    Published in Digestive diseases and sciences (01-03-2023)
    “…Background and Study Aims Weight reduction is the mainstay treatment for Nonalcoholic steatohepatitis (NASH). intragastric balloon (IGB) placement has proven…”
    Get full text
    Journal Article
  19. 19
  20. 20